Antibiotic resistance: What to do now?;Resistencia a antibióticos: ¿Qué hacer ahora?

Medicina Clinica

Volumn 119, Issue 17, 2002, Pages 656-658

  Campos, José ^a   Baquero, Fernando ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; ERYTHROMYCIN; OXACILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; DRUG SURVEILLANCE PROGRAM; DRUG USE; EDITORIAL; GENETIC PREDISPOSITION; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; RISK ASSESSMENT; SPAIN; STAPHYLOCOCCUS AUREUS;

EID: 17044444995     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(02)73531-8     Document Type: Editorial

References (25)

1. Dirección General de Aseguramiento y Planificación Sanitaria. Agencia de Evaluación de Tecnologías Sanitarias, Ministerio de Sanidad y Consumo. Informe sobre resistencia microbiana. ¿qué hacer? Med Clin (Barc) 1995;106:267-79.
2. CDC. Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR 2002;51:565-7.
3. Davidson R, Cavalcanti R, Brunton JL, Bast DJ, Azavedo JCS, Kibsey P, et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med 2002;346:747-50.
4. Oteo J, Cruchaga S, Campos J, Sáez-Nieto JA, Baquero F y los miembros españoles del Grupo del European Antimicrobial Resistance Surveillance System. Resistencia a antibióticos en Staphylococcus aureus aislados en sangre en 31 hospitales españoles de la Red Europea de Vigilancia de Resistencia a Antibióticos (2000). Med Clin (Barc) 2002; 119:361-5.
5. Oteo J, Cruchaga S, Campos J, Sáez-Nieto JA, Baquero F y miembros españoles del Grupo del European Antimicrobial Resistance Surveillance System. Antibiotic resistance in Streptococcus pneumoniae aislados de LCR y sangre en 33 hospitales españoles de la Red Europea de Vigilancia de Resistencia a Antibióticos (2000). [en prensa]. Enferm Infecc Microbiol Clin.
6. WHO global strategy for containment of antimicrobial resistance. Geneve: World Health Organization, 2001.
7. Levin BR. Minimizing potential resistance: a population dynamics view. Clin Infect Dis 2001;33(Suppl 3):161-9.
8. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999;96:1152-6.
9. McEwen SA, Fedorka-Cray PJ. Antimicrobial use and resistance in animals. Clin Infect Dis 2002;35(Suppl 3):93-106.
10. Cars O, Mölstad S, Melander, A. Variation in antibiotic use in the European Union. Lancet 2001;357:1851-2.
11. Ruiz Bremón A, Ruiz Tovar, M, Pérez Gorricho B, Díaz de Torres P, López Rodriguez R. Non-hospital consumption of antibiotics in Spain: 1987-1997. J Antimicrob Chemother 200;45:395-400.
12. Lázaro Bengoa E, Madurga Sanz M, Abajo Iglesias F. Evolución del consumo de antibióticos en España, 1985-2000. Med Clin (Barc) 2002; 118:561-8.
13. Martínez Sanz H, Castera Melchor E, Catalá Pizarro RM, Cobos García FJ, Sacristán de Lama MP, Sora Ortega M. Utilización de antiinfecciosos en los hospitales españoles: evolución 1997-1999. Farmacia Hosp 2001; 25:3-12.
14. Bronzwaer SL, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002;8:278-82.
15. McCraig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002;287:3096-102.
16. Pichichero ME. Dynamics of antibiotic prescribing for children. JAMA 2002;287:3133-5.
17. Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA 1008;279:875-7.
18. Barden LS, Dowell SF, Schwarts B, Lackey C. Current attitudes regarding use of antimicrobial agents. Clin Pediatr (Phila) 1998;37:665-72.
19. Perz JF, Craig AS, Coffey CS, Jorgensen DM, Mitchel E, May S, et al. Changes in antibiotic prescribing for children after a community-wide campaign. JAMA 2002;287:3103-9.
20. González R, Steiner JF, Lum A, Barrett PH. Decreasing antibiotic use in ambulatory practice. JAMA 1999;281:1512-9.
21. Travers K, Barza M. Morbility of infections caused by antimicrobial-resistant bacteria. Clin Infect Dis 2002;35(Suppl 3):131-4.
22. Baquero F, Negri MC, Morosini MI, Blázquez J. Antibiotic-selective environments. Clin Infect Dis 1998;27(Suppl 1):5-11.
23. Maiden MCJ. Horizontal genetic exchange, evolution, and spread of antibiotic resistance in bacteria. Clin Infect Dis 1998;27(Suppl 1):12-20.
24. Ochman H, Lawrence J, Groisman E. Lateral gene transfer and the nature of bacterial innovation. Nature 2000;405:299-304.
25. Nunes-Düby S, Kwon H, Tirumalai R, Ellenberger T, Landy A. Similarities and differences among 105 memebers of the Int family of site-specific recombinases. Nucleic Acids Res 1998;26:391-406.